Catherine Schulte
Stock Analyst at Baird
(4.34)
# 397
Out of 5,131 analysts
142
Total ratings
60.83%
Success rate
13.57%
Average return
Main Sectors:
Stocks Rated by Catherine Schulte
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| A Agilent Technologies | Maintains: Outperform | $142 → $165 | $147.99 | +11.49% | 18 | Nov 25, 2025 | |
| EXAS Exact Sciences | Maintains: Outperform | $72 → $88 | $102.23 | -13.92% | 15 | Nov 4, 2025 | |
| AVTR Avantor | Maintains: Outperform | $15 → $17 | $12.28 | +38.44% | 14 | Oct 24, 2025 | |
| MTD Mettler-Toledo International | Maintains: Neutral | $1,210 → $1,230 | $1,491.99 | -17.56% | 10 | Aug 4, 2025 | |
| TMO Thermo Fisher Scientific | Maintains: Outperform | $553 → $567 | $615.45 | -7.87% | 28 | Jul 24, 2025 | |
| DHR Danaher | Maintains: Outperform | $226 → $229 | $239.00 | -4.18% | 11 | Jul 23, 2025 | |
| MRVI Maravai LifeSciences Holdings | Maintains: Neutral | $3 → $2 | $3.94 | -49.24% | 6 | May 13, 2025 | |
| QGEN Qiagen | Maintains: Neutral | $40 → $41 | $47.25 | -13.33% | 4 | Apr 21, 2025 | |
| TECH Bio-Techne | Downgrades: Neutral | $88 → $68 | $66.56 | +2.16% | 11 | Feb 19, 2025 | |
| CSTL Castle Biosciences | Maintains: Outperform | $42 → $38 | $39.66 | -4.19% | 7 | Mar 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $56 → $33 | $38.04 | -13.25% | 3 | Nov 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $335 → $281 | $145.55 | +93.06% | 7 | Sep 22, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $208 → $217 | $393.68 | -44.88% | 7 | Oct 30, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $17 → $20 | $235.45 | -91.51% | 1 | Jun 28, 2018 |
Agilent Technologies
Nov 25, 2025
Maintains: Outperform
Price Target: $142 → $165
Current: $147.99
Upside: +11.49%
Exact Sciences
Nov 4, 2025
Maintains: Outperform
Price Target: $72 → $88
Current: $102.23
Upside: -13.92%
Avantor
Oct 24, 2025
Maintains: Outperform
Price Target: $15 → $17
Current: $12.28
Upside: +38.44%
Mettler-Toledo International
Aug 4, 2025
Maintains: Neutral
Price Target: $1,210 → $1,230
Current: $1,491.99
Upside: -17.56%
Thermo Fisher Scientific
Jul 24, 2025
Maintains: Outperform
Price Target: $553 → $567
Current: $615.45
Upside: -7.87%
Danaher
Jul 23, 2025
Maintains: Outperform
Price Target: $226 → $229
Current: $239.00
Upside: -4.18%
Maravai LifeSciences Holdings
May 13, 2025
Maintains: Neutral
Price Target: $3 → $2
Current: $3.94
Upside: -49.24%
Qiagen
Apr 21, 2025
Maintains: Neutral
Price Target: $40 → $41
Current: $47.25
Upside: -13.33%
Bio-Techne
Feb 19, 2025
Downgrades: Neutral
Price Target: $88 → $68
Current: $66.56
Upside: +2.16%
Castle Biosciences
Mar 1, 2023
Maintains: Outperform
Price Target: $42 → $38
Current: $39.66
Upside: -4.19%
Nov 21, 2022
Maintains: Outperform
Price Target: $56 → $33
Current: $38.04
Upside: -13.25%
Sep 22, 2020
Maintains: Neutral
Price Target: $335 → $281
Current: $145.55
Upside: +93.06%
Oct 30, 2019
Maintains: Neutral
Price Target: $208 → $217
Current: $393.68
Upside: -44.88%
Jun 28, 2018
Maintains: Outperform
Price Target: $17 → $20
Current: $235.45
Upside: -91.51%